603707.SH
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 7.78
−2.26%Forward multiples
Based on analyst estimates
- P/E forward
- 16.95x
- P/E 2026E
- 18.97x
- P/E 2027E
- 15.43x
- P/E 2028E
- 11.84x
- P/S forward
- 3.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- 21.61x
- PEG TTM
- 1.08x
- Price / book
- 1.85x
- Price / sales
- 2.99x
- Price / cash flow
- 7.88x
Enterprise value
- Enterprise value
- CNY 11.6B
- EV / sales
- 2.88x
- EV / EBITDA
- 12.30x
- EV / EBIT
- 16.45x
- Market cap
- CNY 12.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026